首页> 中文期刊> 《中国比较医学杂志》 >现代化中药安全性评价和关键技术研究体系的建立与应用

现代化中药安全性评价和关键技术研究体系的建立与应用

         

摘要

中药引起的不良反应事件时有发生,但是目前缺乏科学、客观、规范的中药安全性评价方法.在中药临床前评价的过程中,形成一套科学的、规范的、可行的现代中药评价体系标准势在必行.本项目建立了包括临床前安全性评价用供试品质量控制体系、现代化中药及其制剂毒性评价体系、评价管理体系在内的现代化中药临床前安全性评价体系,规范了中药临床前安全性评价的每个研究环节.无论从保障患者身体健康、增加临床用药的安全性,还是从丰富完善中医药学术、发展中医药学、促进中医药与国际药学相互接轨方面,都具有重要的指导意义和应用价值.%The adverse reactions caused by traditional Chinese medicine have occurred frequently, but there is a lack of scientific,objective and standardized methods for safety evaluation of traditional Chinese medicine.In the process of preclinical evaluation of traditional Chinese medicine, it is imperative to form a set of scientific, standardized and feasible evaluation system of modem Chinese herbal drug.We established the preclinical safety evaluation system of modem Chinese herbal drug including the quality control system of samples for the preclinical safety evaluation, the toxicity evaluation system of modem Chinese herbal drug and its preparation and the evaluation management system, and standardized each research link of preclinical evaluation of traditional Chinese medicine.Whether from protecting patients' health and increasing the safety of clinical medication, or from enriching and improving traditional Chinese medicine science, developing traditional Chinese medicine and promoting mutual connection of traditional Chinese medicine and international medicine, it has important instructional significance and application value.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号